Related Experiment Video
Updated: Feb 8, 2026
15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
10.1K
Replacement Therapies in Metabolic Disease
Alexander S Keller1,2, T C Stevenson Keller Iv1,3, Leon J DeLalio1,2
1Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia, United States.
Current Pharmaceutical Biotechnology
|June 21, 2018
Summary
Replacement therapies have transformed metabolic disease treatment by restoring enzyme function and metabolite levels. Future gene therapies promise to genetically replace defective enzymes, offering new treatment avenues.
Area of Science:
- Biochemistry
- Genetics
- Pharmacology
Background:
- Metabolic diseases historically lacked targeted treatments, relying on symptom management.
- Advancements in understanding molecular pathways enabled metabolite supplementation and enzyme replacement.
- Replacement therapies have revolutionized treatment paradigms for metabolic disorders.
Purpose of the Study:
- To review innovations in enzyme replacement therapy for metabolic diseases.
- To explore the potential of gene therapy for metabolic disorders.
- To discuss future challenges and opportunities in metabolic disease treatment.
Main Methods:
- Review of recent decades of replacement therapy innovation.
- Analysis of modern genetic technologies in enzyme development.
- Examination of gene therapy approaches for metabolic diseases.
Main Results:
- Recombinant enzyme innovation has progressed significantly, replicating endogenous enzymes with optimized delivery and function.
- Gene therapy offers novel therapeutic opportunities by genetically replacing defective enzymes.
- Significant advancements have been made in treating metabolic diseases through enzyme replacement.
Conclusions:
- Enzyme replacement therapy has evolved, with gene therapy emerging as a promising frontier.
- Next-generation treatments aim for genetic correction rather than just enzyme addition.
- Continued innovation is crucial for addressing the challenges and opportunities in metabolic disease management.
Related Concept Videos
01:30Continuous Renal Replacement Therapy
1.1K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.1K
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
229
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
229
00:52What is Metabolism?
132.0K
Overview
132.0K
00:59Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
234
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
234
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
799
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
799